|
FANCE expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.981400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.378000E-01 |
| Normal-vs-Stage2 |
5.588400E-01 |
| Normal-vs-Stage3 |
2.605600E-02 |
| Normal-vs-Stage4 |
2.439200E-01 |
| Stage1-vs-Stage2 |
5.665200E-01 |
| Stage1-vs-Stage3 |
4.040800E-03 |
| Stage1-vs-Stage4 |
1.742620E-01 |
| Stage2-vs-Stage3 |
2.478200E-01 |
| Stage2-vs-Stage4 |
3.557000E-01 |
| Stage3-vs-Stage4 |
4.585200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.932800E-01 |
| Normal-vs-AfricanAmerican |
3.187600E-01 |
| Normal-vs-Asian |
8.317000E-01 |
| Caucasian-vs-AfricanAmerican |
4.761600E-01 |
| Caucasian-vs-Asian |
7.121200E-01 |
| AfricanAmerican-vs-Asian |
5.534200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.913600E-01 |
| Normal-vs-Female |
2.460000E-01 |
| Male-vs-Female |
3.296800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.882400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.007600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.073200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.765700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.498600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.296400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.522800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.401800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.948000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.973200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.575240E-01 |
| Normal-vs-Grade 2 |
4.977400E-01 |
| Normal-vs-Grade 3 |
4.541900E-02 |
| Normal-vs-Grade 4 |
4.409000E-01 |
| Grade 1-vs-Grade 2 |
8.596300E-02 |
| Grade 1-vs-Grade 3 |
3.606100E-02 |
| Grade 1-vs-Grade 4 |
9.464800E-01 |
| Grade 2-vs-Grade 3 |
9.127600E-02 |
| Grade 2-vs-Grade 4 |
3.275400E-01 |
| Grade 3-vs-Grade 4 |
1.776180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.814200E-01 |
| Normal-vs-ccB subtype |
5.523800E-01 |
| ccA subtype-vs-ccB subtype |
2.220200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.102600E-01 |
| Normal-vs-N1 |
1.208230E-01 |
| N0-vs-N1 |
3.252200E-01 |
|
|
